Combinations of bisphosphonates, estrogenic agents and optionally estrogens
CA 2415052 A1 · Owner: American Home Products Corporation · Inventors: Komm, Barry Samuel; Jenkins, Simon Nicholas; Miller, Christopher Paul
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention comprises methods of treating bone disorders and lowering blood LDL levels comprising administration of a bisphosphonate and compound of the formula (I) or (II) wherein Z is a moiety selected from the group of (a) (b), or (c); wherein: R¿1? is selected from H OH or the C¿1?-C¿12? alkyl ethers thereof benzyloxy, or halogen; or C¿1?-C¿4? halogenated ethers including trifluoromethyl ether and trichloromethyl ether; R¿2? R¿3?, R¿4?, R¿5?, and R¿6? are H, OH or C¿1?-C¿12? esters or C¿1?-C¿12? alkyl ethers thereof halogens, or C¿1?-C¿4? halogenated ethers cyano, C¿1?-C¿6? alkyl, or trifluoromethyl with the proviso that, when R¿1? is H, R¿2? is not OH; Y is the moiety (1); R¿7? and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 29, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 29, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 29, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.